Amnesia

Cumulus Neuroscience Presents Data at CTAD 2023 Annual Meeting

Retrieved on: 
Wednesday, October 25, 2023

Data presented at the 16th Clinical Trials on Alzheimer's Disease (CTAD) Annual Meeting provides further validation of the utility of Cumulus Neuroassessment Platform in clinical studies that include patients with mild to moderate cognitive impairment.

Key Points: 
  • Data presented at the 16th Clinical Trials on Alzheimer's Disease (CTAD) Annual Meeting provides further validation of the utility of Cumulus Neuroassessment Platform in clinical studies that include patients with mild to moderate cognitive impairment.
  • BELFAST, Ireland and CAMBRIDGE, Mass., Oct. 25, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, presented data at the Clinical Trials on Alzheimer's Disease (CTAD) Annual Meeting on Wednesday October 25th in Boston, Massachusetts.
  • Cumulus presented three poster presentations, two featuring internally generated data collected from Cumulus-sponsored studies partnering with academic and clinical institutions, and one featuring data generated from a study sponsored by INmune Bio Inc. (Nasdaq: INMB) a clinical stage biopharma company.
  • Cumulus supports precision in CNS clinical trials for its industry partners by enabling remote monitoring of patients across multiple domains of brain function.

Evoke Neuroscience Elevates Cognitive Health with the Evoke EEG Brain Health System

Retrieved on: 
Monday, October 23, 2023

NEW YORK, Oct. 23, 2023 /PRNewswire/ -- Evoke Neuroscience , a leading force in cognitive health, is proud to unveil its latest innovation, the Evoke EEG System with the world's largest human brain EEG and ERP database.

Key Points: 
  • NEW YORK, Oct. 23, 2023 /PRNewswire/ -- Evoke Neuroscience , a leading force in cognitive health, is proud to unveil its latest innovation, the Evoke EEG System with the world's largest human brain EEG and ERP database.
  • Evoke Neuroscience , founded in 2009, has consistently demonstrated its commitment to pioneering advancements in cognitive health.
  • The Evoke EEG Brain Health System: A New Era
    At the core of Evoke Neuroscience 's vision is the Evoke EEG System, a remarkable achievement in the field of cognitive health.
  • The Evoke EEG System is a testament to Evoke Neuroscience 's ongoing dedication to advancing cognitive health.

Women with a Heart Healthy Diet in Midlife are Less Likely to Report Cognitive Decline Later

Retrieved on: 
Friday, October 20, 2023

"With more than 30 years follow-up, we found that the stronger the adherence to a DASH diet in midlife, the less likely women are to report cognitive issues much later in life."

Key Points: 
  • "With more than 30 years follow-up, we found that the stronger the adherence to a DASH diet in midlife, the less likely women are to report cognitive issues much later in life."
  • Longstanding research shows that high blood pressure, particularly in midlife, is a risk factor for cognitive decline and dementia.
  • Self-reported cognitive complaints were assessed using six validated standard questions that are indicative of later mild cognitive impairment, which leads to dementia.
  • Women who adhered most closely to the DASH diet had a 17 percent reduction in the odds of reporting multiple cognitive complaints.

Alzheimer's Association Applauds CMS Decision to Cover PET Imaging for Alzheimer's Disease Diagnosis

Retrieved on: 
Friday, October 13, 2023

CHICAGO, Oct. 13, 2023 /PRNewswire/ -- A valuable Alzheimer's disease diagnostic tool will now be more accessible across the country thanks to a policy change today by the Centers for Medicare & Medicaid Services (CMS). The Alzheimer's Association applauds CMS for taking action to expand coverage of brain amyloid positron emission tomography (PET) imaging for the diagnosis of Alzheimer's disease. In issuing its new policy, CMS said the specific details of the coverage will be made by the Medicare Administrative Contractors (MACs). The Alzheimer's Association urges the MACs to quickly implement broad and equitable coverage for all Medicare beneficiaries.

Key Points: 
  • The Alzheimer's Association applauds CMS for taking action to expand coverage of brain amyloid positron emission tomography (PET) imaging for the diagnosis of Alzheimer's disease.
  • "Amyloid PET scans are a proven tool and can be an important part of Alzheimer's diagnosis and treatment," said Maria C. Carrillo, Ph.D., chief science officer, Alzheimer's Association.
  • "Broader access to amyloid PET scans will enable earlier and more accurate diagnosis, and better care management.
  • The Alzheimer's Association has led the development and implementation of amyloid PET scans in Alzheimer's research, diagnosis and care.

Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease

Retrieved on: 
Wednesday, October 11, 2023

BURLINGTON, N.C., Oct. 11, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch and national availability of its ATN Profile, a blood-based test that combines three, well-researched blood biomarkers to identify and assess biological changes associated with Alzheimer's disease – amyloid plaques, tau tangles and neurodegeneration (ATN) – which can help accelerate the path to diagnosis and intervention.i The test is available through physicians for use with patients who are being evaluated for possible Alzheimer's disease or other causes of cognitive impairment based on clinical observation and cognitive screenings. 

Key Points: 
  • "Many patients experience uncertainty around Alzheimer's disease risk, which can take months or even years to diagnose," said Dr. Brian Caveney, Labcorp's chief medical and scientific officer.
  • Until recently, it has been difficult to specifically identify the biological changes consistent with Alzheimer's disease through widely available methods.
  • "Labcorp's ATN Profile provides easier identification of biological changes consistent with Alzheimer's disease and offers the promise of an accelerated path to diagnosis," said Caveney.
  • With the release of its ATN Profile, Labcorp is reaffirming its dedication to supporting better care and outcomes for those impacted by Alzheimer's disease and other neurodegenerative conditions.

Mindfulness Meditation Application Market to grow by USD 1.48 billion from 2022 to 2027 | Growth Driven by the rising cases of mood disorders- Technavio

Retrieved on: 
Monday, October 9, 2023

The potential growth difference for the mindfulness meditation application market from 2022rom to 2027 is USD 1.48 billion.

Key Points: 
  • The potential growth difference for the mindfulness meditation application market from 2022rom to 2027 is USD 1.48 billion.
  • Get deeper insights into the market size, current market scenario, future growth opportunities, major growth driving factors, the latest trends, and much more.
  • Buy the full report here
    The rising cases of mood disorders are key factors driving market growth.
  • Increased demand may be stimulated by the growing acceptance of mindful meditation techniques as a powerful treatment for mood disorders.

UserWay's Accessibility Compliance Platform Pushes WCAG 2.2 Update, Unlocking Next-Gen Web Accessibility Compliance Standards for Customers

Retrieved on: 
Thursday, October 5, 2023

Today, the World Wide Web Consortium (W3C), the internet's international standards-setting organization, has adopted WCAG 2.2 as the latest standard for accessibility online.

Key Points: 
  • Today, the World Wide Web Consortium (W3C), the internet's international standards-setting organization, has adopted WCAG 2.2 as the latest standard for accessibility online.
  • The U.S. Department of Justice, on August 4, 2023, published proposed rules increasing digital accessibility demands of state and local public entities.
  • Companies who are today compliant using WCAG 2.1 AA standards may no longer be under WCAG 2.2.
  • With its proactive approach and commitment to innovation, UserWay continues to be a trusted partner in the journey toward digital accessibility and compliance.

Award-Winning Horror Novelist Brian James Gage Unveils His Debut AI-Assisted Graphic Novel Series: The Nosferatu Conspiracy

Retrieved on: 
Tuesday, October 3, 2023

LOS ANGELES, Oct. 3, 2023 /PRNewswire-PRWeb/ -- Acclaimed novelist Brian James Gage launches his groundbreaking AI-assisted graphic novel series, The Nosferatu Conspiracy. This graphic serial is based on his trilogy of horror novels of the same name, which have garnered critical acclaim and won multiple awards. The trilogy is now reborn as an epic graphic novel serialization that promises to captivate readers with its rich storytelling and innovative AI-generated artwork.

Key Points: 
  • Acclaimed novelist Brian James Gage launches his groundbreaking AI-assisted graphic novel series, The Nosferatu Conspiracy.
  • LOS ANGELES, Oct. 3, 2023 /PRNewswire-PRWeb/ -- Acclaimed novelist Brian James Gage launches his groundbreaking AI-assisted graphic novel series, The Nosferatu Conspiracy.
  • Brian James Gage is reimagining his haunting trilogy into an ambitious graphic novel serialization that will span an estimated thirty volumes upon completion.
  • Early Praise for The Nosferatu Conspiracy Volume One, Lady of the Loch:
    "...Bewitching...a visually compelling graphic debut that's beautifully executed..."—Book Viral Reviews, Golden Quill Spotlight.

Hepatitis C: Britons getting tattoos and cosmetic procedures abroad may be at risk – here's how to avoid it

Retrieved on: 
Thursday, September 28, 2023

A growing number of people living in the UK are going abroad to have tattoos, piercings and cosmetic surgeries.

Key Points: 
  • A growing number of people living in the UK are going abroad to have tattoos, piercings and cosmetic surgeries.
  • But people heading abroad for cosmetic procedures may want to be extra cautious – with recent reports suggesting thousands of UK residents may have unknowingly contracted hepatitis C this way.
  • Over 170 million people worldwide are estimated to have hepatitis C. There are approximately one million new infections each year.

What is hepatitis C?

    • In rare cases, hepatitis C can also be spread through sexual intercourse, or from an infected mother to an infant during childbirth.
    • But up to 85% of those infected develop chronic hepatitis – where the virus remains in the body.
    • Hepatitis C is still very treatable in chronic form, though treatments have better outcomes the sooner they’re received.
    • An estimated one in five people with chronic hepatitis C develop a severe liver cancer called hepatocellular carcinoma.

Risk from medical or cosmetic procedures

    • Improper sterilisation also carries risk of other diseases, such as HIV and hepatitis B.
    • Several studies have reported that tattoos done in non-professional settings, such as those received in prisons, carry an increased risk of contracting hepatitis C due to improper sterilisation.
    • Even tattoos done in professional tattoo parlours may carry an increased risk if reusable needles aren’t adequately sterilised between clients.
    • Although data is limited, this risk is probably the same for cosmetic and dental procedures.

How can you avoid it?

    • If in the UK, ask to see the business’s licence to ensure they’re registered with a local council.
    • With any injectable, ideally these should be done by a medical professional – such as a nurse or dentist.
    • If it comes back positive, get treated as soon as possible as hepatitis C virus is a highly treatable infection.

The tantalising scent of rain or freshly baked bread: why can certain smells transport us back in time?

Retrieved on: 
Wednesday, September 27, 2023

Simply by living among sawdust and woodchips, you learn to distinguish the different smells of wood.

Key Points: 
  • Simply by living among sawdust and woodchips, you learn to distinguish the different smells of wood.
  • Years after my father retired, I was walking through the underbelly of a hospital when, completely by chance, I stumbled upon the maintenance room.
  • Suddenly and unexpectedly, I was transported back to my native Toledo (in Spain), to my father’s carpentry workshop.

Smells that revive past emotions

    • The scent of freshly baked cakes or bread, the chlorine of a swimming pool in summer, a salty sea breeze, coffee, and rain are smells that cause our minds to recover memories and emotions that we thought long forgotten.
    • Memory is the brain’s ability to compile, store and recover information based on past experiences.
    • Numerous scientific studies have tried to discover how we can recover memories and sensations from the past through a particular smell.

A direct line to emotional memory

    • For this reason, a familiar smell activates the same areas of the brain as those related to emotional memory.
    • In fact, scent induced memories tend to be connected to past experiences with a greater emotional significance than other senses.

The loss of smell, a sign of neurological illness

    • Many of us experienced this first hand during the covid-19 pandemic, when millions of people lost their sense of smell.
    • Intriguingly, many disorders linked to a loss of smell are neurodegenerative, where one of the associated symptoms is memory loss.
    • LH, this reads as though all loss of smell ends up with Alzheimer’s, which i don’t think is what is meant, given the next paragraph.

Olfactory gymnastics to rehabilitate your memory?

    • Consequently, in recent years there has been interest in determining the therapeutic potential of scents to stimulate and rehabilitate memory in patients with neurological disorders.
    • Olfactory enrichment –smelling a range of different scents– can reverse loss of smell caused by an infection, craneal trauma, Parkinson’s and aging.
    • Obviously, more research is needed to definitively conclude that regular olfactory stimulation helps to protect the brain and prevent cognitive decline or impairment.